Endometrial evaluation with transvaginal ultrasound during hormone therapy: a prospective multicenter study

In: Fertility and Sterility · 2004 · vol. 81(6) , pp. 1632–1637 · doi:10.1016/j.fertnstert.2003.10.043 · PMID:15193487 · W2094227767
article OA: bronze CC0 ⤵ 5 in-corpus citations
AI-generated summary by claude@2026-06, 2026-06-08

This prospective multicenter study evaluated the effectiveness of transvaginal ultrasound for assessing the endometrium in women undergoing hormone therapy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectiveTo assess the value of endometrial thickness as a marker of endometrial abnormality risk during hormone therapy (HT) and to study the correlation between abnormal bleeding and abnormal endometrial histology in patients with thick endometrium.DesignProspective multicenter study.SettingUniversity and general hospitals outpatient centers.Patient(s)Postmenopausal women (702) on HT.Intervention(s)Biendometrial thickness was measured by transvaginal sonography (TVS) between day 5 and day 10 after the last P intake and, when present, after the end of the menstrual-like bleeding.Main outcome measure(s)Hysteroscopy and biopsy were performed within 5 days from TVS on all patients with an endometrial thickness >4.5 mm (precision scale 0.5 mm).Result(s)Endometrial thickness >4.5 mm was observed in 20.5% of patients. One hundred sixteen hysteroscopies and biopsies were performed. Hyperplasia, polyps, and endocavitary fibroids were detected in 15%, 24%, and 8% of cases, respectively. The positive predictive value of TVS examination was 47%. Endometrial thickness was the only variable significantly and independently associated with histologic abnormalities and endocavitary fibroids. Abnormal bleeding occurred in 17.1% of patients. Among 17 patients detected with thick endometrium and hyperplasia, 8 cases showed abnormal bleeding.Conclusion(s)Sonographic endometrial thickness of 4.5 mm provides a sensitive tool to select HT patients who might benefit from hysteroscopy and biopsy. Abnormal bleeding is not a sensitive sign of hyperplasia in patients with thick endometrium.

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (23)

Cited by (5)

Source provenance

openalex
last seen: 2026-05-11T06:45:02.717393+00:00
License: CC0 · commercial use OK